Muscle relaxants allergy
- PMID: 22014924
- DOI: 10.1177/03946320110240s306
Muscle relaxants allergy
Abstract
The most common agents that are responsible for intraoperative anaphylaxis are muscle relaxants. In fact, neuromuscular blocking agents (NMBAs) contribute to 50-70 percent of allergic reactions during anaesthesia. The main mechanism of hypersensitivity reactions to NMBAs is represented by acute type I allergic reactions and the most severe form is anaphylaxis. The rate of non IgE mediated immediate hypersensitivity reactions usually varies between 20 percent and 35 percent of the reported cases in most large series. In a recent report, non allergic suspected reactions to NMBAs occurred with almost the same frequency as did those with an allergic component. Although the precise mechanisms of these reactions remain difficult to ascertain, they usually result from direct non specific mast cell and basophil activation. After diagnostic procedures, regardless of the specific IgE results, NMBAs are contraindicated if the skin tests were positive. In view of the constantly evolving anesthesiologic practices, and of the complexity of allergy investigation, an active policy to identify patients at risk and to provide any necessary support to anaesthetists and allergologists should be promoted. The high frequency of IgE anaphylactic reactions and the feasibility of skin tests in children justify systematic allergy testing whenever hypersensitivity reaction occurs during general anaesthesia.
Similar articles
-
Hypersensitivity reactions to neuromuscular blocking agents.Curr Pharm Des. 2008;14(27):2809-25. doi: 10.2174/138161208786369704. Curr Pharm Des. 2008. PMID: 18991700 Review.
-
Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.Anesthesiology. 2003 Sep;99(3):536-45. doi: 10.1097/00000542-200309000-00007. Anesthesiology. 2003. PMID: 12960536
-
Allergy and anaphylaxis in anaesthesia.Minerva Anestesiol. 2004 May;70(5):285-91. Minerva Anestesiol. 2004. PMID: 15181405 Review.
-
[Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002)].Ann Fr Anesth Reanim. 2004 Dec;23(12):1133-43. doi: 10.1016/j.annfar.2004.10.013. Ann Fr Anesth Reanim. 2004. PMID: 15589352 French.
-
Anaphylactic reactions during anaesthesia and the perioperative period.Anaesthesiol Intensive Ther. 2012 Aug 8;44(2):104-11. Anaesthesiol Intensive Ther. 2012. PMID: 22992971 Review.
Cited by
-
Anaphylaxis from atracurium without skin manifestation.J Anaesthesiol Clin Pharmacol. 2014 Jan;30(1):104-5. doi: 10.4103/0970-9185.125717. J Anaesthesiol Clin Pharmacol. 2014. PMID: 24574606 Free PMC article.
-
Atracurium-Induced Bronchospasm With Flat Capnograph at Induction of General Anaesthesia: A Case Report.Cureus. 2024 Feb 15;16(2):e54251. doi: 10.7759/cureus.54251. eCollection 2024 Feb. Cureus. 2024. PMID: 38496062 Free PMC article.
-
Optimal dose of mivacurium for laser-assisted laryngeal microsurgery: a pharmacokinetic study using closed-loop target-controlled infusion.Anaesthesiol Intensive Ther. 2024;56(4):231-240. doi: 10.5114/ait.2024.145249. Anaesthesiol Intensive Ther. 2024. PMID: 39917969 Free PMC article. Clinical Trial.
-
Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant.Toxins (Basel). 2018 Jan 7;10(1):34. doi: 10.3390/toxins10010034. Toxins (Basel). 2018. PMID: 29316656 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical